Key result
In older adults with adrenal tumors, male sex was strongly associated with malignancy (OR 6.35), and a multivariable risk model incorporating clinical and imaging features predicted malignant lesions with an AUC of 0.89.
Why the study?
To investigate age-specific characteristics of adrenal tumors in older adults and identify predictors for adrenal malignancy.
Cohort (n=559)
No
Odds Ratio: 6.35 (95% CI 2.27–19.09)
p-value: p=<0.001
In older adults with adrenal tumors, there is a high prevalence of malignancy (19.0%), primarily metastases, which can be predicted using a model incorporating age, sex, tumor laterality, size, and CT attenuation.
May inform malignancy risk assessment in older adults with adrenal tumors; leaves open need for prospective validation of predictors.
Introduction: To investigate age-specific characteristics of adrenal tumors in older adults and to identify predictors for adrenal malignancy. Methods: Inpatients ≥60 years old with adrenal tumor evaluated at a large medical center between January 2011 and December 2023 were retrospectively enrolled. Results: Of 2,633 inpatients with adrenal tumor, 559 (21.2%, ≥60 years) were eligible for analysis, 52.8% were men, with a median age of 64 years. 58.7% patients were incidentally diagnosed. The median tumor size was 29 mm, and the median unenhanced computed tomographic (CT) attenuation was 15.0 Hounsfield units (HU). Older patients presented a relatively high prevalence of malignant adrenal tumors, accounting for 19.0% of all cases. Adrenal metastases were the most common malignant adrenal tumors, accounting for 59.4% of all malignant cases. A risk model was conducted to predict adrenal malignancy, and the area under the curve was 0.89. Predictors included incidental discovery, male, bilateral tumor, older age, higher HU, and lower weight. The optimal cutoff value was age=67.5 years, size=42.5 mm and CT attenuation=20.5 HU, respectively. Conclusions: Older patients presented the age-specific spectrum of diagnosis, in particular a high prevalence of adrenal metastases. Certain predictors may help to differentiate a malignant lesion from a benign one. This study helps to expand the current knowledge of the adrenal tumor in older adults and inspire robust therapies with better outcomes.
No takes yet. Share an insight, caveat, or question.
Tang et al. (2026) conducted a cohort in Adrenal tumors (n=559). Male sex vs. Female sex was evaluated on Malignant adrenal tumor (OR 6.35, 95% CI 2.27-19.09, p=<0.001). In older adults with adrenal tumors, male sex was strongly associated with malignancy (OR 6.35), and a multivariable risk model incorporating clinical and imaging features predicted malignant lesions with an AUC of 0.89.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: